文献速递骨质疏松与代谢性骨病创伤骨科

2型糖尿病患者髋部骨折终生风险:台湾糖尿病研究

Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study.
PubMed 文献 · Osteoporos Int · 2021-07-06

该回顾性队列研究纳入台湾25275名男性和27953名30-100岁2型糖尿病患者,估算其髋部骨折终生风险。结果显示女性终生累积发生率显著高于男性,且使用噻唑烷二酮类(TZD)和胰岛素与髋部骨折风险的关联强度较大。

要点

  • 女性2型糖尿病患者的髋部骨折终生风险显著高于男性。
  • 使用噻唑烷二酮类或胰岛素与髋部骨折风险显著相关,且关联强度较大。
  • 吸烟、饮酒、糖尿病病程、使用袢利尿剂、糖皮质激素、正常体重或偏瘦、高脂血症和慢阻肺也与髋部骨折风险显著相关。

核心结论

  • 2型糖尿病男性和女性髋部骨折终生风险存在显著性别差异,女性风险更高。
  • 在显著相关因素中,使用噻唑烷二酮类和胰岛素与髋部骨折的关联强度较大。

研究设计与样本

  • 回顾性队列研究,纳入2002-2004年参与台湾全国糖尿病个案管理计划的25275名男性和27953名女性2型糖尿病患者,年龄30-100岁。
  • 采用以年龄为时间尺度的Cox比例风险回归模型分析基线社会人口学因素、生物标志物、合并症与髋部骨折事件。

主要发现

  • 男性在50、60、65、70、75、80、85岁的髋部骨折终生累积发生率(%)分别为0.11、0.40、0.84、1.84、3.82、8.53、16.72。
  • 女性在50、60、65、70、75、80、85岁的髋部骨折终生累积发生率(%)分别为0.05、0.50、1.36、3.89、9.56、21.19、35.45。

关键数值与推荐

  • 多变量调整后与髋部骨折显著相关的因素包括吸烟、饮酒、糖尿病病程、口服降糖药类型(未用药、仅磺脲类、仅TZD或TZD联合其他、其他单药或多种口服药、胰岛素、胰岛素联合口服降糖药)、袢利尿剂使用、糖皮质激素使用、正常体重或偏瘦、高脂血症和慢性阻塞性肺疾病。

临床怎么用

  • 对2型糖尿病患者应评估髋部骨折终生风险,尤其关注女性及使用TZD或胰岛素者。
  • 戒烟限酒、管理糖尿病病程及合并症(如慢阻肺、高脂血症)可能有助于降低髋部骨折风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study is to estimate the lifetime risks of hip fracture in Chinese patients with type 2 diabetes. INTRODUCTION: The lifetime risks of hip fracture have not been reported across the age spectrum in male adults and female adults with type 2 diabetes. METHODS: A retrospective cohort study was conducted on 25275 men and 27953 women with type 2 diabetes aged 30-100 years old and participated in the National Diabetes Case Management Program in 2002-2004 in Taiwan. Sociodemographic factors, biomarkers, and comorbidity at the baseline and hip fracture events were analyzed with Cox proportional hazards regression models with age as the time scale. RESULTS: Significant differences in the lifetime risks of hip fracture were observed between men and women with type 2 diabetes. The cumulative lifetime incidences (%) of hip fracture at 50, 60, 65, 70, 75, 80, and 85 years old for men were 0.11, 0.40, 0.84, 1.84, 3.82, 8.53, and 16.72, respectively. The corresponding lifetime incidences (%) for women at 50, 60, 65, 70, 75, 80, and 85 years old were 0.05, 0.50, 1.36, 3.89, 9.56, 21.19, and 35.45, respectively. With competing risks, the significant multivariate-adjusted hazard ratio of developing hip fracture included smoking, alcohol drinking, duration of diabetes, type of oral hypoglycemic drugs use (no medication, sulfonylurea only, thiazolidinediones (TZD) only or TZD plus others, other single or multiple oral agents, insulin use, insulin plus oral hypoglycemic drug use), loop diuretics use, use of corticosteroids, normal weight or underweight, hyperlipidemia, and chronic obstructive pulmonary disease. CONCLUSIONS: The gender differences in lifetime hip fracture risk were significant. Thiazolidinediones and insulin use are factors with the greater magnitude of strength of association among those significantly associated with hip fracture.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Lin CC, Li CI, Liu CS, et al. Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study. Osteoporos Int. 2021. PMID: 34230998. doi:10.1007/s00198-021-06052-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。